Cas:859155-80-9 2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid manufacturer & supplier

We serve Chemical Name:2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid CAS:859155-80-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid

Chemical Name:2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid
CAS.NO:859155-80-9
Synonyms:2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid
Molecular Formula:C9H7N3O3
Molecular Weight:205.17000
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:89.11000
Exact Mass:205.04900
LogP:1.13820

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid Use and application,2-(5-Methyl-1,2,4-oxadiazol-3-yl)isonicotinic acid technical grade,usp/ep/jp grade.


Related News: Soliris would need a “substantial discount” to reach a more appropriate price, according to its report. Using the widely leveraged measure for disease burden known as quality-adjusted life year (QALY), ICER calculated a range of $6,900 to achieve $50,000 per QALY to $25,700 to hit $200,000 per QALY. 3-methylbutyl 2-(2,4-dichlorophenoxy)acetate manufacturers For these reasons, many pharmaceutical companies are choosing to evaluate biocatalytic processes during early-stage drug development to avoid missing opportunities for capitalizing on these gains. Nicotinic receptor (human mutant c923T?C gene CHRNB2 subunit) suppliers The Lonza team also contains regulatory specialists with experience working with Chinese regulators throughout the drug development and scale-up process. Approximately 250 employees work at Lonza’s Nansha site; this expansion is expected to create around 70 new positions. 4-[4-(2-{[(2S)-3-(4-{[tert-Butyl(diphenyl)silyl]oxy}phenoxy)-2-hydroxypropyl]amino}ethyl)anilino]-N-[3-(4-methylphenyl)propyl]-1-piperidinecarboxamide vendor & factory.